Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AVS Pulse Intravascular Lithotripsy™ (Pulse IVL™) to Open Vessels With Calcific Walls and Enhance Vascular Compliance and Remodeling for Coronary Artery Disease - A First-in-Human (FIH) Study

NCT07510438 is registered in ClinicalTrials.gov with Amplitude Vascular Systems, Inc. as lead sponsor.

NCT NCT07510438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07510438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AVS Pulse Intravascular Lithotripsy™ (Pulse IVL™) to Open Vessels With Calcific Walls and Enhance Vascular Compliance and Remodeling for Coronary Artery Disease - A First-in-Human (FIH) Study
Lead sponsor
Amplitude Vascular Systems, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
May 8, 2026
Completion date
December 31, 2027
Enrollment
15 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

coronary arterial disease (cad)